(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol, 95.0%, 5g

2-Chloro-3,4-dihydroxybenzoic acid, 95.0%, 1g

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride, 97%, 1g

2-(2-Bromo-phenoxy)-propionic acid ethyl ester, 1g

2-Chloro-N-[3-cyano-1-(furan-2-ylmethyl)-4,5-dimethyl-1h-pyrrol-2-yl]acetamide, 97%, 100mg

6-Methoxy-7-hydroxy-3,4-dihydroisoquinoline, 95.0%, 1g

2-Amino-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one, 97%, 1g

methyl 5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoate, 98%, 250mg

N-(4-Bromo-phenyl)-2-hydroxy-5-iodo-benzamide, 95.0%, 1g

Nepsilon-Formyl-L-lysine>98.0%(T)1g

Methyl 4-oxocyclohexanecarboxylate, 95.0%, 10g

(9E,12E)-OCTADECA-9,12-DIENOIC ACID, 98%, 1g

Diethyl 3-(tert-Butyldimethylsilyloxy)glutarate, 95.0%, 25g